January 22, 2012
Fitch Even partner Kendrew H. Colton was quoted in an article published in the December 17, 2012, online and print editions of Chemical & Engineering News, a weekly publication of the American Chemical Society. The article, titled "Protest Over U.S. Price of AIDS Drug," discusses the response expected from the National Institutes of Health (NIH) to a petition asking NIH to override Abbott Laboratories’ patents on the AIDS drug, Norvir, and allow generic production to lower the drug’s cost.
Ken has extensive intellectual property counseling and litigation experience involving patent infringement, contract licensing disputes, copyrights, unfair competition, and trade secrets. His practice specialty is designing strategies to achieve market exclusivity and freedom to operate for clients in established and emerging chemical and biochemical technologies.
- Using Persuasion Techniques to Achieve Litigation Success: Part TwoFitch Even Webinar: April 22, 2021 Read more
- Fitch Even Partner Joe Marinelli to Moderate Program on IP Litigation at ABA Business Law Spring MeetingApril 14, 2021 Read more